Akeso

Asia
Pharma

AZ, Boehringer-Simcere, Daiichi and more—Fierce Pharma Asia

AZ pledged a $15 billion China investment. BI and Simcere inked a potential $1 billion IBD deal. Daiichi is navigating a complex ADC market. And more.
Angus Liu Jan 30, 2026 7:45am
newspaper

Pfizer, Akeso, Lilly and more—Fierce Pharma Asia

Nov 14, 2025 8:50am
Pfizer
Favicon Fierce Biotech

Pfizer lays out its PD-1xVEGF bispecific research strategy

Nov 11, 2025 11:43am
Close up shot of the target from a dart game

Akeso details ivonescimab's 1st overall survival win

Nov 7, 2025 11:30am
Akeso

Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC

Oct 19, 2025 10:45am
Summit

Summit's global PD-1xVEGF data show new promising OS trend

Sep 7, 2025 3:30am